Establishment of South Sichuan Institute of Translational Medicine by School graduates

Prof. Chan Wai-yee, Director of the School of Biomedical Sciences (SBS) and Prof. Cho Chi-hin, Emeritus Professor of SBS attended the opening ceremony of South Sichuan Institute for Translational Medicine (SSITM) held in Luzhou, Sichuan, China on 28 May 2019.

The establishment of SSITM was initiated by Prof. Cho and five Ph.D graduates of SBS who currently worked in Southwest Medical University, Luzhou, including Prof. Xiao Zhangang, Director of SSITM. In the ceremony, Prof. Chan and Prof. Xiao signed a framework agreement between SSITM and SBS to promote collaboration in education and medical technologies in translational medicine between the two institutes.

SSITM focuses on big data mining, next generation sequencing and genome editing that facilitate the discovery of immunotherapies and stem cell-based therapies for cancer treatment. It is well-equipped with a GMP-level laboratory for handling clinical specimens and cell-based therapies. The visit and signing of agreement have established a solid foundation between the School and SSITM to explore collaboration in translating research insights into clinical studies in the future.

Related coverage of Southwest Medical University can be viewed HERE (Chinese version only).

於2019年5月28日,生物醫學院院長陳偉儀教授及榮譽退休教授曹之憲教授前往中國四川瀘州參與川南醫學轉化研究院(研究院)揭牌儀式。

研究院為曹教授及五位現職於瀘州西南醫科大學的本學院五位哲學博士畢業生所發起成立,包括研究院院長肖佔剛。在儀式中,陳偉儀教授與肖佔剛教授簽訂本院與研究院之間的框架協議,以推動兩院在轉化醫學的教育及科技方面的合作交流。

此研究院專注於大數據分析、新一代基因測序及基因編輯,促進研發用於癌症治療的免疫療法和基於細胞的療法。研究院配備GMP級實驗室,用於處理臨床標本和基於細胞的療法。是次訪問和協議簽訂為本院及研究院之間建立了紮實的合作基礎,在未來攜手致力將科研成果轉化為臨床應用。

請按此處瀏覽西南醫科大學刊載的有關報導。

于2019年5月28日,生物医学院院长陈伟仪教授及荣誉退休教授曹之宪教授前往中国四川泸州参与川南医学转化研究院(研究院)揭牌仪式。

研究院为曹教授及五位现职于泸州西南医科大学的本学院五位哲学博士毕业生所发起成立,包括研究院院长肖占刚。在仪式中,陈伟仪教授与肖占刚教授签订本院与研究院之间的框架协议,以推动两院在转化医学的教育及科技方面的合作交流。

此研究院专注于大数据分析、新一代基因测序及基因编辑,促进研发用于癌症治疗的免疫疗法和基于细胞的疗法。研究院配备GMP级实验室,用于处理临床标本和基于细胞的疗法。是次访问和协议签订为本院及研究院之间建立了扎实的合作基础,在未来携手致力将科研成果转化为临床应用。

请按此处浏览西南医科大学刊载的有关报导。

Back to Top